1.Associated factors and prognosis of residual cancer after esophagectomy for squamous cell carcinoma of the esophagus.
Bin ZHENG ; Yi HU ; Jun-Ye WANG ; Hong YANG ; Peng LIN ; Jian-Hua FU
Chinese Journal of Gastrointestinal Surgery 2010;13(1):44-47
OBJECTIVESTo analyze associated factors and the prognosis of patients with residual cancer after esophagectomy for squamous cell carcinoma of the esophagus, and to assess outcomes after salvage treatment.
METHODSClinical and pathological data of 1074 patients with squamous cell carcinoma of the esophagus who underwent esophagectomy in the Cancer Center of Sun Yat-sen University from 1997 to 2003 were analyzed retrospectively. The relationship between the associated factors (differentiation, location, length of the lesion, surgical route, anastomosis site, T stage, N stage) and the incidence of residual cancer was analyzed, using the chi-squared test and Logistic regression analysis methods. The value and the modality of the salvage treatment were investigated.
RESULTSForty-four patients had residual cancer (4.3%). Cancers in the upper esophagus were associated with the highest incidence of residual cancer on esophageal stump (6.5%), while the lower esophagus had the highest incidence of residual cancer on gastric stump (0.78%). The Incidence correlated with T and N stage. Logistic regression analysis showed that T and N stage were the risk factors of residual cancer. Three-year survival rate was 22.7% in patients with residual cancer. The mean survival time was 25.2+/-3.3 months. Three-year survival rates of patients with and without salvage treatment were 53.2% and 7.8%, respectively (P=0.027). Three-year survival rate of patients with salvage radiotherapy was 56.0%.
CONCLUSIONSAdvanced T and N stage are the risk factors of residual cancer after esophagectomy in the patients with squamous cell carcinoma of the esophagus. Salvage treatment can improve the survival of the patients.
Adult ; Aged ; Carcinoma, Squamous Cell ; diagnosis ; pathology ; surgery ; Esophageal Neoplasms ; diagnosis ; pathology ; surgery ; Esophagectomy ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm, Residual ; epidemiology ; Prognosis ; Retrospective Studies
2.Value of Second Pass in Loop Electrosurgical Excisional Procedure.
Kidong KIM ; Soon Beom KANG ; Hyun Hoon CHUNG ; Tack Sang LEE ; Jae Weon KIM ; Noh Hyun PARK ; Yong Sang SONG
Journal of Korean Medical Science 2009;24(1):110-113
The aim of this study was to compare the rate of incomplete resection and treatment outcome of the second-pass technique with those of single-pass technique in loop electrosurgical excisional procedure (LEEP). From 1997 to 2002, 683 women were diagnosed as squamous dysplasia via LEEP in our institution. Age, parity, LEEP technique, grade of lesion, glandular extension, margin status, residual tumor and recurrence were obtained by reviewing medical records. Positive margin was defined as mild dysplasia or higher grade lesions at resection margin of the LEEP specimen. In women who underwent hysterectomy, residual tumor was defined as mild dysplasia or higher grade lesions in hysterectomy specimen. In women who did not underwent hysterectomy, Pap smear more than atypical squamous cells of undetermined significance or biopsy result more than mild dysplasia within two years after LEEP were regarded as cytologic or histologic recurrences, respectively. Treatment failure of LEEP was defined as residual tumor or histologic recurrence. The second-pass technique significantly reduced the endocervical margin positivity (odds ratio [OR], 0.36; 95% confidence interval [CI], 0.21-0.63). However, the second-pass technique did not reduce the treatment failure (OR, 0.62; 95% CI, 0.29-1.32). In conclusion, the second-pass technique markedly reduced the endocervical margin positivity, but did not reduce the treatment failure rate of LEEP.
Adult
;
Cervical Intraepithelial Neoplasia/pathology/*surgery
;
Electrosurgery/*methods
;
Female
;
Humans
;
Hysterectomy
;
Medical Records
;
Middle Aged
;
Neoplasm Recurrence, Local/diagnosis/epidemiology
;
Neoplasm, Residual/diagnosis/epidemiology
;
Odds Ratio
;
Recurrence
;
Retrospective Studies
;
Risk Factors
;
Severity of Illness Index
;
Uterine Cervical Neoplasms/pathology/*surgery
3.Hypoxia-inducible factor-1α and CD133 predicts pathological complete response and survival for locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy.
Cheng CAI ; Jianping WANG ; Zhifeng ZHONG ; Zhihui DAI ; Qinghua WANG ; Wuzhen DONG ; Hongqi SHI ; Qingwei LIU ; Jinlin DU
Journal of Zhejiang University. Medical sciences 2017;46(1):36-43
To investigate the expression of hypoxia-inducible factor 1α (HIF-1α) and CD133 in predicting pathologic remission and survival of patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.One hundred and fourteen patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy from January 2010 to December 2015 in Jinhua Municipal Central Hospital were enrolled in the study. RT-PCR and immunohistochemistry methods were used to detect the mRNA and protein expression of HIF-1α and CD133 before and after chemoradiotherapy. Spearman rank correlation was used to analyze the correlation between HIF-1α and CD133 mRNA expression. Univariate and logistic multivariate analyses were used to determine the factors related to pathological complete response (pCR). Logistic regression analysis and Cox's proportional hazard model were used to determine factors related to overall survival and recurrence-free survival.The expression of HIF-1α and CD133 mRNA was correlated with pT, ypTNM, pCR, recurrence and metastasis of rectal cancer, while not correlated with sex, age and BMI of patients. HIF-1α mRNA expression was positively correlated with CD133 mRNA expression (=0.579,=0.000). Immunohistochemistry analysis showed that residual cancer cells strongly expressing HIF-1α also expressed CD133 strongly. Univariate analysis showed that HIF-1α mRNA and CD133 mRNA were significantly correlated with pCR (=0.001,=0.022, respectively). Multivariate analysis showed that HIF-1α and CD133 mRNA expression were independent prognostic factors of pCR (=0.012,=0.047, respectively). Cox regression analysis showed that the expression of HIF-1α mRNA and CD133 mRNA were independent predictors of recurrence-free survival and overall survival (=0.025,=0.033, respectively).The study indicates that HIF-1α and CD133 can predict pathological complete remission and survival of patients with locally advanced rectal cancer.
AC133 Antigen
;
analysis
;
genetics
;
Biomarkers, Tumor
;
analysis
;
Chemoradiotherapy
;
Disease-Free Survival
;
Female
;
Humans
;
Hypoxia-Inducible Factor 1, alpha Subunit
;
analysis
;
genetics
;
Male
;
Neoadjuvant Therapy
;
Neoplasm Grading
;
Neoplasm Metastasis
;
diagnosis
;
Neoplasm Recurrence, Local
;
epidemiology
;
genetics
;
Neoplasm, Residual
;
genetics
;
Prognosis
;
Proportional Hazards Models
;
Rectal Neoplasms
;
chemistry
;
epidemiology
;
genetics
;
therapy
;
Survival Rate